RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Safety and tolerability of glucagon-like peptide-1 receptor agonists utilizing data from the exenatide clinical trial development program

Safety and tolerability of glucagon-like peptide-1 receptor agonists utilizing data from the exenatide clinical trial development program

Add to Collection
RCTs H Peng, LL Want, VR Aroda - Current diabetes reports, 2016 - Springer

Chapter : Section9
Journal Year : 2016
Cited by : 24

… type 2 diabetes including A1C reduction and weight loss with minimal risk of hypoglycemia. This … Specific areas covered include comparative risk of hypoglycemia, as well as pancreatic, …..... Read More

Keywords : ['glucagonlike receptor agonist utilize datum', 'exenatide clinical trial development program', 'tolerability', 'safety']
PubMed Link : https://link.springer.com/article/10.1007/s11892-016-0728-4
Google Scholar Link : https://scholar.google.com/scholar?cites=3566071206808756586&as_sdt=800005&sciodt=0,15&hl=en&num=20